Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella Pertussis

Clinical trial NCT01160081 · COMPLETED

Trial details

NCT number: NCT01160081
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Viral Hepatitis Vaccines Hepatitis A Cytomegalovirus Varicella-Zoster Virus Bordetella Pertussis Infection Herpes Simplex (1 and 2)

Start date: 2010-03-01
Primary completion: 2010-09-01
Enrollment: 3658

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.